
(Reuters) - Endo International Plc on Tuesday said it had agreed to pay $10 million to avoid going to trial in October in a landmark case by two Ohio counties accusing various drug manufacturers and distributors of fueling the U.S. opioid epidemic.
Endo said as part of the agreement-in-principle it had reached with Cuyahoga and Summit counties, it had also agreed to provide up to $1 million of two of its drug products free of charge.
Original Article
No comments
Post a Comment